Indian Market Analysis - Newborn Cord Blood Stem Cell Banking Market 2019 - 20

1. Indian Market Analysis - Newborn Cord Blood Stem Cell Banking Market 2019 - 20 One of the most effective ways to protect the health of your child is to store its stem cells at birth. To bank the precious stem cells of the baby when they born could become a crucial step in the treatment of any critical disease in the future. What are Stem cells? Stem cells are biological cells that can divide and transform into another type of cell with a more specialized function, such as a muscle cell, red blood cell, or a brain cell. Stem cells are the building blocks of blood and immune systems that act as a system for repairing and maintaining tissues, organs and blood vessels by replacing cells the damaged or diseased cells of the body. Stem cells mainly provide innate healing and hold a promising role in the field of regenerative medicine. Stem cells are the undifferentiated cells which have the capability of renewing itself, rapidly multiplying, and differentiating into different functional cells. Treatments resulting from biomedical research in the area of stem cell therapy are expected to treat various diseases such as diabetes, cardiology, cancer, arthritis, and neurology. What are New-born Stem Cells Banking? Stem cell banking for long-term storage through various stem cell platforms for patient-specific clinical applications is a fundamental source for preserving the original characteristics of stem cells. Stem cell banking is the method of collection, processing and storage of the cord blood stem cells. Immediately after the delivery of the baby the cord blood is collected and processed for harvesting the stem cells. It is a rich source of stem cells and these umbilical cord stem cell benefits to treat thousands of disorders, which include various forms of leukemia, lymphoma, and anemia. Stem cell banking is non-invasive and does not harm the mom or child. The method of collecting cord blood is secure, painless, easy and quick. For doing the cord blood transplant at least 75 mL of sample is collected. This quantity of blood guarantees that enough stem cells are accessible for the method of transplantation to occur. The next stage is cord blood storage. As it is a biological material, it will be assessed to confirm that infections like HIV or hepatitis and other complications do not occur. Once this is achieved, the process of storage is done by cryopreservation. A cryopreservant is added with the blood, allowing the blood to start freezing slowly. To maintain the neurons intact throughout the method, the continuous method is required. Stem cell research has made rapid progress in recent years, raising both hope and hype in the public mind, especially among patients with incurable diseases.

2. New-born Stem Cells Banking Market The stem cell banking market is divided into placental stem cells, bone-marrow stem cells, fat- tissue stem cells, dental pulp stem cells and other undifferentiated sources of stem cells. Moreover, stem cells have been proven to treat ~80 diseases and disorders including hematopoietic disorders, immunodeficiency diseases, metabolic disorders, cancer, and degenerative neuromuscular disorders. Understanding the Market Need of Stem Cell Banking Increase in the diseases such as cancer and cardiovascular diseases had affected a huge portion of global population. Diabetes is another disease having high rate of occurrence. There are some other diseases requiring long-term and extensive treatment, including surgical procedures. Major drugs used to treat these diseases are unable to cure these diseases. Currently, stem cells have successfully been used in the treatment of blood and immune- related disorders (including leukemia and immunological disorders). This is expected to replicate into increased research funding to develop novel stem cell therapies as well as the growing adoption of stem cell banking services, so as to utilize them for future applications. Market drivers of stem cell banking •Increase in number of childbirths •Simple system of extraction •Stem Cells in Disease Treatment is potential •Support from government authorities for research and development for clinical trials of cord stem cell •Umbilical Cord Cell Banks potential is growing •Growing knowledge and awareness of cord stem Therapeutics Market analysis of stem cell banking The industry of stem cell banking is the fastest growing throughout the world where number of cord blood banks are increasing every year. However, there are still some challenges leftover in this field and to overcome the challenges it is important to know about the strengths and opportunities of stem cell banking. This can be done by help of SWOT Analysis. Strengths: •Cord blood stem cells are completely non-controversial because they are derived from living newborns. •Cord blood is a very versatile biological material, as it can be used to treat a wide range of blood diseases, genetic disorders, metabolic disorders and various types of cancer. •Cord blood stem cells are easily available, collection procedure is safe and risk-free.

3. Weakness: •Participation in the cord blood industry can involve costly accreditation requirements, including AABB accreditation, FACT accreditation, ISO certifications, and more. •Cord blood banks must maintain protective measures and strategies to protect themselves against emergencies, natural disasters, electrical failures and man-made disasters which substantially increases operating costs. Opportunities •Stem cells extracted from cord blood gets perfectly matched with the recipient, •Cord blood stem cells do not possess any type of rejection so there are no chances of occurrence of graft vs host disease. •Cord blood stem cells do not possess the chances of getting any kind of infection, such as cytomegalovirus, etc. Threats •Public stem cell banks do not charge any fee for storing the stem cells. •There are some other banks which charges fee of storing for one year then the sample is transferred to the public registry. •Standing on this point private stem cell bank have to face the problem of charges as they had to possess the charges of processing and storage as they are keeping the sample stem cells in the name of the client for lifetime. Future of stem cell banking in India Healthcare sector is one of the most lucrative business in India and in this sector stem cell banking has gained enormous popularity. The reason behind is that it is the radical innovation in the field of medical science. As per WHO, India is now a country with 26 million births per year and it has become one of the largest countries from where umbilical cord can be harvested. This matter explains the increase in the growing interest of the stem cell banking companies of India. In addition to this the fact that India has become one of the popular places for medical treatment has also led the country as a preferred destination for stem cell banking. Private companies such as Cordlife India, Lifecell, Reliance Lifesciences and public cord blood banks such as Jeevan Stem Cell have reinvented the promising industry of stem cell banking in India.